What are the side effects of Ixazomib/Enleri? How long will it take to disappear

Ixazomib/Ixazomib, as a new oral proteasome inhibitor, although effective in the treatment of multiple myeloma, is also accompanied by a series of side effects. According to clinical studies and patient reports, the most common adverse reactions include thrombocytopenia, neutropenia, diarrhea, constipation, peripheral neuropathy, nausea, peripheral edema, rash, vomiting, and bronchitis. Among them, thrombocytopenia and neutropenia are the most significant and frequent, especially when combined with other chemotherapy drugs, the probability of these side effects will be higher.

Specifically, thrombocytopenia may make patients prone to bleeding or bruising, while neutropenia increases the risk of infection. These hematological abnormalities usually require regular blood routine monitoring so that appropriate countermeasures can be taken in a timely manner. At the same time, diarrhea and constipation are common adverse reactions of the digestive system. Patients may experience mild to moderate diarrhea, which is usually characterized by increased stool frequency and changes in stool consistency.

In addition to the above-mentioned common side effects, some more serious adverse events have also been observed after marketing, such as angioedema and toxic epidermal necrolysis. Although such adverse reactions are rare, they require immediate medical treatment once they occur. It is important for patients to understand these potential side effects so that they can communicate with their doctor promptly if symptoms occur.

Most side effects usually appear within a few days to weeks after taking the medication and gradually resolve after stopping the medication or adjusting the dose. However, if certain side effects persist for longer than expected or show a tendency to become more severe, patients should seek professional medical advice promptly. The doctor may adjust the treatment plan according to the specific situation to ensure the patient's safety and therapeutic effect.